Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-05-17 @ 10:04 PM
Study NCT ID:
NCT01087151
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2010-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Organization: